Literature DB >> 9465483

Beyond inflammation: site-directed immunotherapy.

L A Lampson1.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 9465483     DOI: 10.1016/s0167-5699(97)01181-x

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


× No keyword cloud information.
  4 in total

Review 1.  New animal models to probe brain tumor biology, therapy, and immunotherapy: advantages and remaining concerns.

Authors:  L A Lampson
Journal:  J Neurooncol       Date:  2001-07       Impact factor: 4.130

2.  Robust ability of IFN-gamma to upregulate class II MHC antigen expression in tumor bearing rat brains.

Authors:  Tanya Dutta; Alexander Spence; Lois A Lampson
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

Review 3.  Brain tumor immunotherapy: an immunologist's perspective.

Authors:  Lois A Lampson
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

4.  Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy.

Authors:  Hideho Okada; Frank S Lieberman; Howard D Edington; Timothy F Witham; Mark J Wargo; Quan Cai; Elaine H Elder; Theresa L Whiteside; S Clifford Schold; Ian F Pollack
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.